SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-002188
Filing Date
2024-02-29
Accepted
2024-02-29 16:15:49
Documents
106
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ymab-20231231x10k.htm   iXBRL 10-K 2720547
2 EX-4.2 ymab-20231231xex4d2.htm EX-4.2 29166
3 EX-10.34 ymab-20231231xex10d34.htm EX-10.34 78674
4 EX-10.46 ymab-20231231xex10d46.htm EX-10.46 59672
5 EX-21.1 ymab-20231231xex21d1.htm EX-21.1 1759
6 EX-23 ymab-20231231xex23.htm EX-23 2717
7 EX-31.1 ymab-20231231xex31d1.htm EX-31.1 16250
8 EX-31.2 ymab-20231231xex31d2.htm EX-31.2 16372
9 EX-32.1 ymab-20231231xex32d1.htm EX-32.1 6838
10 EX-32.2 ymab-20231231xex32d2.htm EX-32.2 6406
11 EX-97.1 ymab-20231231xex97d1.htm EX-97.1 33773
12 GRAPHIC ymab-20231231x10k001.jpg GRAPHIC 68345
  Complete submission text file 0001558370-24-002188.txt   10758013

Data Files

Seq Description Document Type Size
13 EX-101.SCH ymab-20231231.xsd EX-101.SCH 76867
14 EX-101.CAL ymab-20231231_cal.xml EX-101.CAL 61419
15 EX-101.DEF ymab-20231231_def.xml EX-101.DEF 314815
16 EX-101.LAB ymab-20231231_lab.xml EX-101.LAB 627682
17 EX-101.PRE ymab-20231231_pre.xml EX-101.PRE 535048
108 EXTRACTED XBRL INSTANCE DOCUMENT ymab-20231231x10k_htm.xml XML 1565179
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38650 | Film No.: 24703859
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)